PEPTIDES ARE BACK! Following the withdrawal of nominations, the FDA will now remove 12 peptides from Category 2 and bring them before the Pharmacy Compounding Advisory Committee (PCAC) beginning July 23 24, 2026. BPC 157 BPC 157 Research Peptide: Advancing Laboratory Discoveries Dihexa (also known as PNB 0408) is an experimental small molecule derived from angiotensin IV. It was engineered to cross the bloodbrain barrier and has shown synaptogenic effects in preclinical models. The often quoted The Wolverine Peptide Stack: BPC 157 + TB 500 Dosage and Protocol Is Dihexa an approved and safe treatment for cognitive impairment or neurodegenerative diseases such as Alzheimer disease?